Eli Lilly (LLY) Return on Capital Employed Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
806.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
1,180.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
632.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-1,083.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
486.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
341.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-467.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
479.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
806.00 |
| Dec 31, 2025 |
406.00 |
| Sep 30, 2025 |
960.00 |
| Jun 30, 2025 |
747.00 |
| Mar 31, 2025 |
1,002.00 |
| Dec 31, 2024 |
270.00 |
| Sep 30, 2024 |
110.00 |
| Jun 30, 2024 |
991.00 |
| Mar 31, 2024 |
485.00 |
| Dec 31, 2023 |
482.00 |
| Sep 30, 2023 |
83.00 |
| Jun 30, 2023 |
-575.00 |
| Mar 31, 2023 |
-445.00 |
| Dec 31, 2022 |
373.00 |
| Sep 30, 2022 |
462.00 |
| Jun 30, 2022 |
686.00 |
| Mar 31, 2022 |
546.00 |
| Dec 31, 2021 |
110.00 |
| Sep 30, 2021 |
260.00 |
| Jun 30, 2021 |
-13.00 |
| Mar 31, 2021 |
-358.00 |
| Dec 31, 2020 |
-78.00 |
| Sep 30, 2020 |
-153.00 |
| Jun 30, 2020 |
-24.00 |
| Mar 31, 2020 |
360.00 |
| Dec 31, 2019 |
372.00 |
| Sep 30, 2019 |
351.00 |
| Jun 30, 2019 |
345.00 |
| Mar 31, 2019 |
393.00 |
| Dec 31, 2018 |
197.00 |
| Sep 30, 2018 |
172.00 |
| Jun 30, 2018 |
204.00 |
| Mar 31, 2018 |
35.00 |
| Dec 31, 2017 |
167.00 |
| Sep 30, 2017 |
301.00 |
| Jun 30, 2017 |
238.00 |
| Mar 31, 2017 |
191.00 |
| Dec 31, 2016 |
126.00 |
| Sep 30, 2016 |
-101.00 |
| Jun 30, 2016 |
77.00 |
| Mar 31, 2016 |
65.00 |
| Dec 31, 2015 |
3.00 |
| Sep 30, 2015 |
77.00 |
| Jun 30, 2015 |
-323.00 |
| Mar 31, 2015 |
-539.00 |
| Dec 31, 2014 |
-866.00 |
| Sep 30, 2014 |
-1,020.00 |
| Jun 30, 2014 |
-663.00 |
| Mar 31, 2014 |
-210.00 |
| Dec 31, 2013 |
228.00 |
| Sep 30, 2013 |
437.00 |
| Jun 30, 2013 |
154.00 |
| Mar 31, 2013 |
-178.00 |
| Dec 31, 2012 |
-492.00 |
| Sep 30, 2012 |
-706.00 |
| Jun 30, 2012 |
-570.00 |
| Mar 31, 2012 |
-494.00 |
| Dec 31, 2011 |
-235.00 |
| Sep 30, 2011 |
-135.00 |
| Jun 30, 2011 |
22.00 |
| Mar 31, 2011 |
129.00 |
| Dec 31, 2010 |
-654.00 |
